Form 4 for CVRX CVRx, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001415889-25-006481 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-02-28 | CVRX | Adamson Philip B. | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2025-03-04 | 2025-02-28 | CVRX | Adamson Philip B. | Chief Medical Off | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | A | A | 20,000 | $0.00 | 20,000 | D | — | — | (F1) Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. |
| 2 | Derivative | Stock Option (right to buy) | 2025-02-28 | A | A | 30,000 | $0.00 | 30,000 | D | $12.96 · — to 2035-02-27 | 30,000 Common Stock | (F2) Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. |